{"id":303906,"date":"2010-02-10T18:13:39","date_gmt":"2010-02-10T23:13:39","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=62801"},"modified":"2010-02-10T18:13:39","modified_gmt":"2010-02-10T23:13:39","slug":"lifevantage-raises-2-6-million","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/303906","title":{"rendered":"Lifevantage Raises $2.6 Million"},"content":{"rendered":"\n<div style=\"text-transform:uppercase\"><a href=\"http:\/\/www.xconomy.com\/tag\/Life-Sciences\/\">Life Sciences<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/funding\/\">funding<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/nutraceuticals\/\">Nutraceuticals<\/a><\/div>\n<p>\t\t<strong>Denise Gellene wrote:<\/strong><\/p>\n<p>Lifevantage (OTCBB: <a href=\"http:\/\/finance.yahoo.com\/q?s=LFVN\">LFVN<\/a>), a San Diego-based nutraceuticals company, raised $2.6 million of a $5 million securities offering that included debt and options, warrants or other rights to acquire another security, <a href=\"http:\/\/www.sec.gov\/Archives\/edgar\/data\/849146\/000120919110007986\/xslFormDX01\/primary_doc.xml\">according to a regulatory filing. <\/a>The filing didn&#8217;t say how the funds would be used.<\/p>\n<div class=\"postFooter\"><a href=\"http:\/\/www.xconomy.com\/san-diego\/2010\/02\/10\/lifevantage-raises-2-6-million\/#comments\">Comments<\/a> | <a href=http:\/\/www.xconomy.com\/reprints\/>Reprints<\/a> | Share: &nbsp;<br \/>\n<a href=\"http:\/\/twitter.com\/home?status=RT%20@Xconomy%20Lifevantage%20Raises%20$2.6%20Million%20http:\/\/xconomy.com\/?p=62801\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/twitter.gif\" alt=\"Retweet\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/www.facebook.com\/sharer.php?u=http:\/\/www.xconomy.com\/san-diego\/2010\/02\/10\/lifevantage-raises-2-6-million\/&#038;t=Lifevantage%20Raises%20$2.6%20Million\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/facebook.gif\" alt=\"Facebook\"\/><\/a><br \/>\n&nbsp;<a href=http:\/\/www.xconomy.com\/san-diego\/2010\/02\/10\/lifevantage-raises-2-6-million\/email\/  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/email.gif\" alt=\"Email\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/sharethis.com\/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=Lifevantage+Raises+%242.6+Million&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fsan-diego%2F2010%2F02%2F10%2Flifevantage-raises-2-6-million%2F\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/share.gif\" alt=\"Share\"\/><\/a>\n<\/div>\n<p>\t     \t\t<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=d4dc2a9e0ba1f49c15d5e24e7109902a&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=d4dc2a9e0ba1f49c15d5e24e7109902a&#038;p=1\"\/><\/a><br \/>\n<img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"0\" width=\"0\" border=\"0\" style=\"display:none\" src=\"http:\/\/a.rfihub.com\/eus.gif?eui=2218\"\/><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/B3vcE7pP15uaTukVBTiNStnNfgE\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/B3vcE7pP15uaTukVBTiNStnNfgE\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/B3vcE7pP15uaTukVBTiNStnNfgE\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/B3vcE7pP15uaTukVBTiNStnNfgE\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Xconomy_Full\/~4\/IJnhY5zNW7s\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Life Sciences, funding, Nutraceuticals Denise Gellene wrote: Lifevantage (OTCBB: LFVN), a San Diego-based nutraceuticals company, raised $2.6 million of a $5 million securities offering that included debt and options, warrants or other rights to acquire another security, according to a regulatory filing. The filing didn&#8217;t say how the funds would be used. Comments | Reprints [&hellip;]<\/p>\n","protected":false},"author":2918,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-303906","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/303906","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/2918"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=303906"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/303906\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=303906"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=303906"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=303906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}